Identification of Early-Stage Breast Cancer with a Minimal Risk of Recurrence by the Breast Cancer Index
The adjusted BCI model identified women with early-stage, hormone receptor-positive N0 breast cancer at a minimal risk of DR who may consider de-escalating adjuvant endocrine therapy.
Authors
- Jenna Wong (ORCID: https://orcid.org/0009-0008-3211-5343)
- Ranelle Salunga
- Bo Nordenskjöld (ORCID: https://orcid.org/0000-0002-2134-7586)
- Gerrit‐Jan Liefers (ORCID: https://orcid.org/0000-0001-7326-8313)
- Olle Stål (ORCID: https://orcid.org/0000-0002-8290-0592)
- Linda de Munck (ORCID: https://orcid.org/0000-0002-2930-509X)
- Amanda K. L. Anderson (ORCID: https://orcid.org/0000-0001-7686-7477)
- Yi Zhang (ORCID: https://orcid.org/0009-0006-4642-2147)
- Kai Treuner (ORCID: https://orcid.org/0009-0006-3443-3578)
- Esther Bastiaannet (ORCID: https://orcid.org/0000-0001-8469-9813)
- Tommy� Fornander
- Wilma E. Mesker (ORCID: https://orcid.org/0000-0001-5533-4778)
- Marie-France Jilderda (ORCID: https://orcid.org/0009-0003-2851-8223)
- Valerie Rebattu
Institutions
- Linköping University (SE)
- Leiden University (NL)
- University of Zurich (CH)
- Leiden University Medical Center (NL)
- Prevention Institute (US)
- Karolinska Institutet (SE)
- Svenska Örtmedicinska Institute (SE)
- Theranostics (New Zealand) (NZ)
- Biothera (United States) (US)
- Hologic (United States) (US)
- Netherlands Comprehensive Cancer Organisation (NL)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-3836
- Citations
- 2
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.09